Anti‐CD20 therapeutic options in immune‐mediated thrombotic thrombocytopenic purpura

por Maitta, Robert W.
Publicado 2022

Alpha synuclein in hematopoiesis and immunity

por Pei, Yu, Maitta, Robert W.
Publicado 2019

Immature Platelet Dynamics in Immune-Mediated Thrombocytopenic States

por Reeves, Hollie M., Maitta, Robert W.
Publicado 2020

Steady Increment of Immature Platelet Fraction Is Suppressed by Irradiation in Single-Donor Platelet Components during Storage

por Hong, Hong, Xiao, Wenbin, Maitta, Robert W.
Publicado 2014

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy

por Maitta, Robert W., Reeves, Hollie M., Fontaine, Magali J.
Publicado 2023

Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome

por Bittencourt, Cassiana E., Ha, Jennifer P., Maitta, Robert W.
Publicado 2015

Correction: Re-Examination of 30-Day Survival and Relapse Rates in Patients with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome

por Bittencourt, Cassiana E., Ha, Jennifer P., Maitta, Robert W.
Publicado 2015

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances

por Maitta, Robert W., Raval, Jay S., Reeves, Hollie M., Fontaine, Magali J.
Publicado 2021

Chronic red cell exchange in sickle cell patients with iron overload may not affect mortality

por Zhou, Yi Yuan, Reeves, Hollie M., Webb, LaRhonda, Santiago, Zamira, Maitta, Robert W.
Publicado 2022